VIRMA and colorectal carcinoma: Collectively, our findings indicate that circTAX1BP1 in CAF‐derived EVs promotes CRC progression by regulating SP1 m6A modification through lactylated VIRMA, thereby activating the TGF‐β/Smad pathway and facilitating CRC progression.